CA Stock MarketDetailed Quotes

MSCL Satellos Bioscience Inc

Watchlist
  • 0.640
  • +0.010+1.59%
15min DelayMarket Closed Apr 29 16:00 ET
106.12MMarket Cap2.56P/E (TTM)

Satellos Bioscience Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-115.58%-24.98M
-209.84%-7.81M
-9.45%-4.38M
-46.00%-5.66M
-499.24%-7.13M
-105.30%-11.59M
-124.40%-2.52M
-153.25%-4M
-356.99%-3.88M
43.14%-1.19M
Net income from continuing operations
-76.85%-28.1M
6.56%-6.11M
-153.23%-9.05M
-46.68%-6.04M
-314.71%-6.91M
-40.34%-15.89M
-28.87%-6.54M
-88.20%-3.57M
-84.01%-4.12M
21.26%-1.67M
Operating gains losses
-192.10%-1.46M
-135.62%-685K
107.83%120K
-115.57%-185K
-23,666.67%-707K
6,228.00%1.58M
--1.92M
---1.53M
--1.19M
--3K
Depreciation and amortization
185.71%20K
500.00%12K
0.00%3K
200.00%3K
100.00%2K
-97.92%7K
-84.62%2K
-97.26%3K
-99.07%1K
-99.06%1K
Asset impairment expenditure
--3.96M
--0
----
----
----
--0
--0
----
----
----
Remuneration paid in stock
-2.58%2.11M
-47.66%447K
-68.15%237K
87.30%693K
266.17%736K
50.63%2.17M
242.97%854K
140.15%744K
-11.71%370K
-56.47%201K
Other non cashItems
-375.71%-488K
----
----
----
----
226.43%177K
----
----
----
----
Change In working capital
-377.78%-1.03M
-193.30%-988K
-15.87%350K
90.27%-134K
-193.36%-253K
-62.76%369K
36.65%1.06M
517.04%416K
-259.93%-1.38M
149.67%271K
-Change in receivables
86.69%-43K
-90.79%-435K
27,000.00%813K
62.93%-109K
-259.18%-312K
-220.97%-323K
-356.00%-228K
575.68%3K
-184.94%-294K
761.67%196K
-Change in prepaid assets
-2,213.73%-2.36M
-2,506.76%-1.93M
-15.00%-69K
-1,684.21%-301K
-569.23%-61K
-5,000.00%-102K
-669.23%-74K
-68.80%-60K
2,370.74%19K
-33.04%13K
-Change in payables and accrued expense
73.55%1.38M
1.10%1.38M
-183.30%-394K
125.05%276K
93.55%120K
9.37%794K
67.61%1.36M
831.64%473K
-314.34%-1.1M
111.58%62K
Cash from discontinued investing activities
Operating cash flow
-115.58%-24.98M
-209.84%-7.81M
-9.45%-4.38M
-46.00%-5.66M
-499.24%-7.13M
-100.33%-11.59M
-99.52%-2.52M
-153.25%-4M
-356.99%-3.88M
43.14%-1.19M
Investing cash flow
Cash flow from continuing investing activities
136.14%6.34M
33.68%-11.62M
177,150.00%17.71M
33,714.29%2.35M
-2.1M
-584,500.00%-17.54M
-17.52M
-350.86%-10K
-7K
0
Net PPE purchase and sale
66.67%-6K
--0
--0
42.86%-4K
---2K
-500.00%-18K
---1K
-350.86%-10K
---7K
--0
Net investment purchase and sale
136.21%6.34M
33.68%-11.62M
--17.71M
--2.36M
---2.1M
---17.52M
---17.52M
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
136.14%6.34M
33.68%-11.62M
177,150.00%17.71M
33,714.29%2.35M
---2.1M
-584,500.00%-17.54M
---17.52M
-350.86%-10K
---7K
--0
Financing cash flow
Cash flow from continuing financing activities
5.69%53.49M
12,570.26%53.25M
110.95%221K
-99.97%16K
0
1,723.64%50.61M
-6,000.00%-427K
-172.57%-2.02M
50.8M
2.25M
Net issuance payments of debt
--0
--0
--0
--0
--0
---378K
---94K
---2.53M
--1K
--2.24M
Net common stock issuance
31.85%42.8M
--42.8M
--0
----
----
1,069.84%32.46M
--0
--0
----
----
Proceeds from stock option exercised by employees
-41.76%10.68M
--10.45M
--221K
----
----
--18.34M
--0
--0
----
----
Net other financing activities
----
----
----
----
----
----
----
----
----
--8K
Cash from discontinued financing activities
Financing cash flow
6.06%53.49M
8,915.89%53.25M
110.95%221K
-99.97%16K
--0
1,717.26%50.43M
-8,528.57%-604K
-172.57%-2.02M
--50.8M
--2.25M
Net cash flow
Beginning cash position
1,046.93%22.07M
-47.08%23.42M
-79.83%9.83M
339.48%13.11M
1,046.93%22.07M
-60.50%1.92M
1,313.70%44.26M
2,424.03%48.73M
7.51%2.98M
-60.50%1.92M
Current changes in cash
63.56%34.85M
263.82%33.82M
324.77%13.55M
-107.01%-3.29M
-969.21%-9.23M
842.11%21.31M
-1,726.99%-20.65M
-601.98%-6.03M
5,631.59%46.92M
150.71%1.06M
Effect of exchange rate changes
163.97%744K
126.89%417K
-97.25%43K
100.51%6K
14,000.00%278K
-1,430.26%-1.16M
-1,914.29%-1.55M
215,824.14%1.56M
-36,890.97%-1.17M
-18.62%-2K
End cash Position
161.29%57.66M
161.29%57.66M
-47.08%23.42M
-79.83%9.83M
339.48%13.11M
1,046.93%22.07M
1,046.93%22.07M
1,313.86%44.26M
2,424.03%48.73M
7.51%2.98M
Free cash from
-115.30%-24.98M
-209.72%-7.81M
-9.18%-4.38M
-45.84%-5.66M
-499.41%-7.13M
-100.54%-11.6M
-99.60%-2.52M
-153.53%-4.01M
-357.81%-3.88M
43.17%-1.19M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -115.58%-24.98M-209.84%-7.81M-9.45%-4.38M-46.00%-5.66M-499.24%-7.13M-105.30%-11.59M-124.40%-2.52M-153.25%-4M-356.99%-3.88M43.14%-1.19M
Net income from continuing operations -76.85%-28.1M6.56%-6.11M-153.23%-9.05M-46.68%-6.04M-314.71%-6.91M-40.34%-15.89M-28.87%-6.54M-88.20%-3.57M-84.01%-4.12M21.26%-1.67M
Operating gains losses -192.10%-1.46M-135.62%-685K107.83%120K-115.57%-185K-23,666.67%-707K6,228.00%1.58M--1.92M---1.53M--1.19M--3K
Depreciation and amortization 185.71%20K500.00%12K0.00%3K200.00%3K100.00%2K-97.92%7K-84.62%2K-97.26%3K-99.07%1K-99.06%1K
Asset impairment expenditure --3.96M--0--------------0--0------------
Remuneration paid in stock -2.58%2.11M-47.66%447K-68.15%237K87.30%693K266.17%736K50.63%2.17M242.97%854K140.15%744K-11.71%370K-56.47%201K
Other non cashItems -375.71%-488K----------------226.43%177K----------------
Change In working capital -377.78%-1.03M-193.30%-988K-15.87%350K90.27%-134K-193.36%-253K-62.76%369K36.65%1.06M517.04%416K-259.93%-1.38M149.67%271K
-Change in receivables 86.69%-43K-90.79%-435K27,000.00%813K62.93%-109K-259.18%-312K-220.97%-323K-356.00%-228K575.68%3K-184.94%-294K761.67%196K
-Change in prepaid assets -2,213.73%-2.36M-2,506.76%-1.93M-15.00%-69K-1,684.21%-301K-569.23%-61K-5,000.00%-102K-669.23%-74K-68.80%-60K2,370.74%19K-33.04%13K
-Change in payables and accrued expense 73.55%1.38M1.10%1.38M-183.30%-394K125.05%276K93.55%120K9.37%794K67.61%1.36M831.64%473K-314.34%-1.1M111.58%62K
Cash from discontinued investing activities
Operating cash flow -115.58%-24.98M-209.84%-7.81M-9.45%-4.38M-46.00%-5.66M-499.24%-7.13M-100.33%-11.59M-99.52%-2.52M-153.25%-4M-356.99%-3.88M43.14%-1.19M
Investing cash flow
Cash flow from continuing investing activities 136.14%6.34M33.68%-11.62M177,150.00%17.71M33,714.29%2.35M-2.1M-584,500.00%-17.54M-17.52M-350.86%-10K-7K0
Net PPE purchase and sale 66.67%-6K--0--042.86%-4K---2K-500.00%-18K---1K-350.86%-10K---7K--0
Net investment purchase and sale 136.21%6.34M33.68%-11.62M--17.71M--2.36M---2.1M---17.52M---17.52M--0--0--0
Cash from discontinued investing activities
Investing cash flow 136.14%6.34M33.68%-11.62M177,150.00%17.71M33,714.29%2.35M---2.1M-584,500.00%-17.54M---17.52M-350.86%-10K---7K--0
Financing cash flow
Cash flow from continuing financing activities 5.69%53.49M12,570.26%53.25M110.95%221K-99.97%16K01,723.64%50.61M-6,000.00%-427K-172.57%-2.02M50.8M2.25M
Net issuance payments of debt --0--0--0--0--0---378K---94K---2.53M--1K--2.24M
Net common stock issuance 31.85%42.8M--42.8M--0--------1,069.84%32.46M--0--0--------
Proceeds from stock option exercised by employees -41.76%10.68M--10.45M--221K----------18.34M--0--0--------
Net other financing activities --------------------------------------8K
Cash from discontinued financing activities
Financing cash flow 6.06%53.49M8,915.89%53.25M110.95%221K-99.97%16K--01,717.26%50.43M-8,528.57%-604K-172.57%-2.02M--50.8M--2.25M
Net cash flow
Beginning cash position 1,046.93%22.07M-47.08%23.42M-79.83%9.83M339.48%13.11M1,046.93%22.07M-60.50%1.92M1,313.70%44.26M2,424.03%48.73M7.51%2.98M-60.50%1.92M
Current changes in cash 63.56%34.85M263.82%33.82M324.77%13.55M-107.01%-3.29M-969.21%-9.23M842.11%21.31M-1,726.99%-20.65M-601.98%-6.03M5,631.59%46.92M150.71%1.06M
Effect of exchange rate changes 163.97%744K126.89%417K-97.25%43K100.51%6K14,000.00%278K-1,430.26%-1.16M-1,914.29%-1.55M215,824.14%1.56M-36,890.97%-1.17M-18.62%-2K
End cash Position 161.29%57.66M161.29%57.66M-47.08%23.42M-79.83%9.83M339.48%13.11M1,046.93%22.07M1,046.93%22.07M1,313.86%44.26M2,424.03%48.73M7.51%2.98M
Free cash from -115.30%-24.98M-209.72%-7.81M-9.18%-4.38M-45.84%-5.66M-499.41%-7.13M-100.54%-11.6M-99.60%-2.52M-153.53%-4.01M-357.81%-3.88M43.17%-1.19M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More